Mark von Itzstein
Corporate Officer/Principal presso Deakin University
Profilo
Mark von Itzstein is the founder of Glykoz Pharma Discovery Pty Ltd., which was founded in 2002, where he held the title of Board Member & Research Director.
He currently holds a position as a Member at Deakin University.
He formerly held a position as a Member at Meditech Research Ltd.
Posizioni attive di Mark von Itzstein
| Società | Posizione | Inizio |
|---|---|---|
| Deakin University | Corporate Officer/Principal | - |
Precedenti posizioni note di Mark von Itzstein
| Società | Posizione | Fine |
|---|---|---|
Meditech Research Ltd.
 Meditech Research Ltd. BiotechnologyHealth Technology Meditech was an Australian biotechnology company focusing on the development of carbohydrate-based therapeutics. The company's platform technology HyACT™ was a drug-delivery technology shown to be highly effective in treating a variety of cancer types. The company was Located in Victoria, Australia. | Corporate Officer/Principal | - |
Glykoz Pharma Discovery Pty Ltd.
 Glykoz Pharma Discovery Pty Ltd. Pharmaceuticals: MajorHealth Technology Glykoz Pharma Discovery Pty Ltd. develops carbohydrate based drugs. It also develops drug candidates for licensing to international biotechnology and pharmaceutical companies. The company was founded by Andrew Loch, Ross Coppel, Karyn Joyner, Mark von Itzstein and Richard J. McElhinney on 5 December, 2006 and is headquartered in Nerang, Australia. | Fondatore | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Glykoz Pharma Discovery Pty Ltd.
Glykoz Pharma Discovery Pty Ltd. Pharmaceuticals: MajorHealth Technology Glykoz Pharma Discovery Pty Ltd. develops carbohydrate based drugs. It also develops drug candidates for licensing to international biotechnology and pharmaceutical companies. The company was founded by Andrew Loch, Ross Coppel, Karyn Joyner, Mark von Itzstein and Richard J. McElhinney on 5 December, 2006 and is headquartered in Nerang, Australia. | Health Technology |
Meditech Research Ltd.
Meditech Research Ltd. BiotechnologyHealth Technology Meditech was an Australian biotechnology company focusing on the development of carbohydrate-based therapeutics. The company's platform technology HyACT™ was a drug-delivery technology shown to be highly effective in treating a variety of cancer types. The company was Located in Victoria, Australia. | Health Technology |
- Borsa valori
- Insiders
- Mark von Itzstein
